← Back to Search

Behavioral Intervention

HeartSteps for Physical Activity

N/A
Waitlist Available
Led By Donna Spruijt-Metz, MFA, PhD
Research Sponsored by University of Southern California
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals are able to participate in mild or moderate physical activity
They are competent to give informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 minutes
Awards & highlights

Study Summary

This trial will test if providing sedentary adults with contextually tailored suggestions and plans for physical activity will help them to be more active.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
30 minute step count
Daily step count
Secondary outcome measures
Moderate or Vigorous Physical Activity (MVPA)

Trial Design

1Treatment groups
Experimental Treatment
Group I: HeartSteps InterventionExperimental Treatment1 Intervention
For activity suggestions, at each available decision time, each participant is randomly assigned to either receive an activity suggestion or not.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HeartSteps
2020
N/A
~100

Find a Location

Who is running the clinical trial?

University of California, San DiegoOTHER
1,116 Previous Clinical Trials
1,519,867 Total Patients Enrolled
University of Southern CaliforniaLead Sponsor
899 Previous Clinical Trials
1,595,221 Total Patients Enrolled
Arizona State UniversityOTHER
281 Previous Clinical Trials
108,842 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~20 spots leftby Mar 2025